The Ureteral Stents Market is gaining momentum due to the increasing prevalence of kidney stones and urinary tract disorders worldwide. Ureteral stents provide an effective method for restoring urinary drainage when the ureter becomes obstructed. Their use across stone management, kidney transplantation, tumors, and other urological procedures makes them an essential component of modern urology care.

The market was valued at USD 668.0 million in 2025, according to Market Research Future. It is expected to grow from USD 711.8 million in 2026 to USD 1,259.9 million by 2035, representing a CAGR of 6.55% throughout the 2026–2035 forecast period.

Kidney stones are one of the most significant demand generators for ureteral stents. Market Research Future estimates that kidney stone applications represented approximately 56.8% of the market in 2025. Increased incidence of nephrolithiasis has resulted in greater utilization of ureteroscopic procedures, lithotripsy, and associated drainage interventions. Changes in dietary habits, sedentary lifestyles, and demographic factors are contributing to the growing clinical burden of kidney stones.

The expansion of minimally invasive surgery is further supporting market development. Compared with traditional open procedures, minimally invasive urological techniques can reduce recovery time and hospital stays. Ureteral stents are frequently used during these procedures to maintain ureteral patency and facilitate urine drainage.

Product preferences are also changing. Double pigtail stents held approximately 42.1% of market share in 2025 because their coiled configuration supports stable positioning and broad clinical use. Meanwhile, biodegradable stents are emerging as a high-growth product category. Their projected 10.75% CAGR through 2035 reflects growing interest in technologies that can potentially eliminate secondary removal procedures.

Hospitals represented approximately 63.0% of end-user demand in 2025. Nevertheless, ambulatory surgical centers are increasingly becoming important as healthcare systems move appropriate urological interventions into outpatient environments. This shift can support demand for compact, easy-to-use, and procedure-specific stent kits.

North America remains the leading regional market, holding approximately 38.5% of global revenue. Asia-Pacific is expected to grow faster than other regions, supported by healthcare infrastructure expansion in India, China, and other emerging economies.

With rising kidney stone prevalence, improved minimally invasive techniques, and continued product innovation, the Ureteral Stents Market is positioned for sustained growth over the coming decade.